Special Issues

Transcatheter Therapies in Congenital and Structural Heart Disease: From Bench to Bedside, Innovation, Evidence, and Outcomes

Submission Deadline: 25 February 2027 View: 47 Submit to Special Issue

Guest Editors

Dr. Raymond Haddad

Email: raymondhaddad@live.com

Affiliation: Congenital and Pediatric Cardiology, Marie-Lannelongue Hospital, INSERM, UMR-S1358, Paris Saclay University, Le Plessis-Robinson, France

Homepage:

Research Interests: congenital heart diseases, interventional cardiology, pediatrics

image1 (4).jpeg


Summary

Congenital and structural heart diseases represent a rapidly expanding and increasingly complex field in both pediatric and adult cardiology. Over the past two decades, transcatheter therapies have transformed clinical practice, shifting treatment from open surgery to minimally invasive, image-guided interventions. Advances in device engineering, off-label use of existing devices, multimodality imaging, computational modeling, and procedural simulation have accelerated the translation of innovation into routine care. As indications broaden to more complex anatomies and higher-risk patients, and as lifelong follow-up becomes standard, the field demands stronger evidence, refined patient selection, and rigorous assessment of short- and long-term outcomes.


This Special Issue, "Transcatheter Therapies in Congenital and Structural Heart Disease: From Bench to Bedside, Innovation, Evidence, and Outcomes," aims to provide a comprehensive, forward-looking overview of emerging technologies, off-label device use, translational research, clinical evidence, and long-term outcomes. In addition to original research, the collection emphasizes high-quality literature reviews that synthesize current evidence, clarify controversies, and define future research priorities.


Topics include transcatheter treatment of complex congenital defects; structural valve interventions; Fontan and single-ventricle therapies; procedural complications and reinterventions; registry analyses and multicenter studies of routine practice; long-term outcomes and quality of life; case reports of unusual findings; novel device development and off-label innovations; multimodality imaging and 3D procedural planning; computational simulation and 3D printing; and precision-based approaches to structural interventions.


Keywords

3D modeling, clinical outcomes, congenital heart disease, device closure, device innovation, evidence synthesis, literature review, multimodality imaging, stent implantation, structural heart disease, transcatheter interventions, translational research

Share Link